SCHEMBL13330278

SCHEMBL13330278

COC(=O)c1sc(N2CCC(NC(=O)c3[nH]c(C)c(Cl)c3Cl)CC2)nc1-c1nccc(N2CCN(C)CC2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13330005 0.93 — —
SCHEMBL10170579 0.89 — —
SCHEMBL10170586 0.84 — —
SCHEMBL510077 0.82 — —
SCHEMBL10214988 0.81 — —
SCHEMBL5139122 0.81 — —
SCHEMBL10170580 0.80 ABCC2 (0.57) —
SCHEMBL3285115 0.78 MAPT (0.51) —
SCHEMBL509657 0.78 — —
SCHEMBL13071263 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010067123-A1 2- (PIPERIDIN-1-YL) -4-HETEROCYCLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2010-06-17 — — WO disclosed
Send feedback